Bellevue Group AG - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16,007,142
-18.1%
580,600
-10.7%
0.26%
-7.5%
Q2 2023$19,546,695
+339.1%
650,256
+429.2%
0.28%
+329.2%
Q1 2023$4,451,979
+12.4%
122,881
+10.7%
0.06%
+22.6%
Q4 2022$3,961,011
-1.9%
111,046
-6.9%
0.05%
-8.6%
Q3 2022$4,038,000
+69.5%
119,278
+44.8%
0.06%
+70.6%
Q2 2022$2,383,000
+25.0%
82,400
+39.7%
0.03%
+54.5%
Q1 2022$1,907,000
-80.8%
59,000
-89.3%
0.02%
-88.6%
Q1 2020$9,945,000
-27.2%
552,800
-4.0%
0.19%
-10.6%
Q4 2019$13,653,000
+19.3%
575,600
+38.2%
0.22%
+1.4%
Q3 2019$11,448,000
-25.9%
416,600
-10.8%
0.21%
-19.3%
Q2 2019$15,453,000
+51.5%
467,000
+60.5%
0.26%
-52.9%
Q1 2019$10,197,000
-11.1%
291,000
-15.7%
0.56%
-25.6%
Q4 2018$11,464,000
-41.1%
345,100
-10.7%
0.75%
-38.9%
Q3 2018$19,460,000
-0.4%
386,500
+18.3%
1.23%
-25.9%
Q2 2018$19,547,000
+47.8%
326,600
+13.1%
1.67%
+27.2%
Q1 2018$13,227,000
+38.1%
288,800
+20.1%
1.31%
+30.9%
Q4 2017$9,580,000
+186.7%
240,400
+46.6%
1.00%
+59.1%
Q2 2016$3,341,000
-50.3%
164,000
-62.8%
0.63%
-48.4%
Q1 2016$6,725,000441,0001.22%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders